Procedural sedation and analgesia with propofol (PSA) for gynecologic surgery: A systematic review of the literature

• Published in: European journal of obstetrics & gynecology and reproductive biology Vol. 287; pp. 137 - 146
• Main Authors: van der Meulen, Julia F., Fisch, Charlotte, Dreessen, Janique R.J., Coppus, Sjors F.P.J., Kok, Helen S., Bongers, Marlies Y.
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 01.08.2023
• Subjects: Analgesia - methods; Female; Gynecologic surgery; Gynecologic Surgical Procedures - adverse effects; Humans; Pain, Postoperative - drug therapy; Procedural sedation and analgesia; Propofol; Propofol - adverse effects; Uterine Prolapse; Procedural sedation and analgesia; Gynecologic surgery; Propofol
• ISSN: 0301-2115; 1872-7654
• DOI: 10.1016/j.ejogrb.2023.05.035

To identify which gynecologic procedures are eligible to be performed under PSA with propofol and to describe safety and effectiveness of these procedures in this setting. A systematic review of the literature was conducted in Pubmed (MEDLINE), Embase and The Cochrane Library from inception until September 21st 2022. Cohort studies and randomized controlled trials were included when they reported on clinical outcomes of gynecologic procedures under procedural sedation and analgesia in which propofol was used as an anesthetic. Studies were excluded when sedation without propofol was used, when they only mentioned the use of procedural sedation and analgesia but did not describe any clinical outcome parameters or when < 10 patients were included. The primary outcome parameter was completeness of procedure. Secondary outcome parameters were type of gynecologic procedure, intraoperative complication rate, patient satisfaction, postoperative pain, duration of hospital admission, patient’s discomfort and ease of procedure as judged by the surgeon. The Cochrane risk of bias tool and the ROBINS-I tool were used for bias assessment. A narrative synthesis of the findings from the included studies was provided. Numbers and percentages were presented, as well as means with standard deviations and medians with interquartile range where applicable. Eight studies were included. A total of 914 patients underwent gynecologic surgical procedures with procedural sedation and analgesia with propofol. Gynecological procedures varied from hysteroscopic procedures, vaginal prolapse surgery and laparoscopic procedures. The percentage of complete procedures was 89.8%−100%. Complications occurred in 0–6.5% of patients. Other outcomes were measured in various ways, but overall patient satisfaction was high and postoperative pain was low. The use of PSA with propofol is promising for a wide range of gynecologic procedures, including hysteroscopic procedures, vaginal prolapse surgery and laparoscopic procedures. The use of PSA with propofol seems to be effective and safe and leads to high degree of patient satisfaction. More research is needed in order to determine for which types of procedures PSA can be used.